Magdalena Mielczarek-Puta

Magdalena Mielczarek-Puta

Auto-generated profile, based on publicly available information

Magdalena Mielczarek-Puta

Chair and Department of Biochemistry, Faculty of Medicine, Medical University of Warsaw

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2003 in Clinica Chimica Acta
Verified
Journal Article
Closed access
ZPZofia Porembska
Zofia Porembska
GLGrzegorz Luboiński
Grzegorz Luboiński
ACAlicja Chrzanowska
Alicja Chrzanowska
MMMagdalena Mielczarek
Magdalena Mielczarek
JMJoanna Magnuska
Joanna Magnuska
ABAnna Barańczyk-Kuźma
Anna Barańczyk-Kuźma

16 March 2016 in Postępy Higieny I Medycyny Doświadczalnej
Verified
Journal Article
Open access
DODagmara Otto-Ślusarczyk
Dagmara Otto-Ślusarczyk
WGWojciech Graboń
Wojciech Graboń
MMMagdalena Mielczarek-Puta
Magdalena Mielczarek-Puta
Aspartate aminotransferase is an organ-nonspecific enzyme located in many tissues of the human body where it catalyzes reversible reaction of transamination. There are two aspartate aminotransferase isoforms--cytoplasmic (AST1) and mitochondrial (AST2), that usually occur together and interact with each other metabolically. Both isoforms are homodimers containing highly conservative regions responsible for catalytic properties of enzyme. The common feature of all aspartate aminotransfeses is Lys - 259 residue covalent binding with prosthetic group - pyridoxal phosphate. The differences in the primary structure of AST isoforms determine their physico-chemical, kinetic and immunological properties. Because of the low concentration of L-aspartate (L-Asp) in the blood, AST is the only enzyme, which supply of this amino acid as a substrate for many metabolic processes, such as urea cycle or purine and pyrimidine nucleotides in the liver, synthesis of L-arginine in the kidney and purine nucleotide cycle in the brain and the skeletal muscle. AST is also involved in D-aspartate production that regulates the metabolic activity at the auto-, para- and endocrine level. Aspartate aminotransferase is a part of the malate-aspartate shuttle in the myocardium, is involved in gluconeogenesis in the liver and kidney, glyceroneogenesis in the adipose tissue, and synthesis of neurotransmitters and neuro-glial pathway in the brain. Recently, the significant role of AST in glutaminolysis - normal metabolic pathway in tumor cells, was demonstrated. The article is devoted the role of AST, known primarily as a diagnostic liver enzyme, in metabolism of various human tissues and organs.

1 March 2009 in Clinical Biochemistry
Verified
Journal Article
Closed access
WGWojciech Graboń
Wojciech Graboń
MMMagdalena Mielczarek-Puta
Magdalena Mielczarek-Puta
ACAlicja Chrzanowska
Alicja Chrzanowska
ABAnna Barańczyk-Kuźma
Anna Barańczyk-Kuźma

23 May 2002 in Cancer
Verified
Journal Article
Open access
PDF file
ZPZofia Porembska
Zofia Porembska
ASAnna Skwarek
Anna Skwarek
MMMagdalena Mielczarek
Magdalena Mielczarek
ABAnna Barańczyk‐Kuźma
Anna Barańczyk‐Kuźma
BACKGROUND: Colorectal carcinoma (CRC) is one of the most common malignancies. In the current work, the role of arginase as a diagnostic marker in patients with recurrent CRC and colorectal liver metastases (CRCLM) was studied.METHODS: Arginase activity was monitored in serum from 40 patients with primary CRC and from 100 patients with CRCLM. Blood was taken before and after patients underwent tumor resection. Studies were conducted for 3 years.RESULTS: Preoperative arginase activity in serum from patients with CRC and CRCLM was much greater compared with the arginase activity in serum from healthy control blood donors. One and two cut‐off levels of increased arginase activity were observed in patients with CRC and CRCLM, respectively. After patients underwent tumor resection, the arginase activity decreased to normal values in both patients with CRC and patients with CRCLM. Activity levels remained low in patients who did not develop recurrent CRC or CRCLM (first or second). In patients who developed subsequent recurrences or metastases that appeared after surgery, during 3 years of surveillance, a significant rise in serum arginase activity was observed. The clinical prognosis for patients was worst when the postoperative serum arginase activity was very high, because those patients more often developed second liver metastases or died.CONCLUSIONS: The authors conclude that the determination of serum arginase activity may be a complementary test to confirm the occurrence of CRC and may be useful for the early diagnosis of patients who develop recurrent CRC and/or CRCLM. Cancer 2002;94:2930–4. © 2002 American Cancer Society.DOI 10.1002/cncr.10563

1 August 2014 in Clinical Biochemistry
Verified
Journal Article
Closed access
ACAlicja Chrzanowska
Alicja Chrzanowska
WGWojciech Graboń
Wojciech Graboń
MMMagdalena Mielczarek-Puta
Magdalena Mielczarek-Puta
ABAnna Barańczyk-Kuźma
Anna Barańczyk-Kuźma

13 May 2020 in Xenobiotica
Verified
Journal Article
Closed access
GKGrażyna Kubiak-Tomaszewska
Grażyna Kubiak-Tomaszewska
PTPiotr Tomaszewski
Piotr Tomaszewski
JPJan Pachecka
Jan Pachecka
MSMarta Struga
Marta Struga
WOWioletta Olejarz
Wioletta Olejarz
Grażyna NowickaGrażyna Nowicka
Grażyna Nowicka
Ethanol, as a small-molecule organic compound exhibiting both hydrophilic and lipophilic properties, quickly pass through the biological barriers. Over 95% of absorbed ethanol undergoes biotransfor...